CD8A and psoriasis: Treatment with commissioned Longkui Yinxiao Tablet for 8 weeks resulted in higher CD4+/CD8+ and CD4+ levels in the psoriasis treatment group and lower CD8+ and cytokines TNF-α, IL-6, and IL-17 levels compared with the control group (Dai et al., 2018).